Birth outcome from a prospective, matched study of prenatal crack/cocaine use: I. Interactive and dose effects on health and growth

Pediatrics

Volumn 101, Issue 2, 1998, Pages 229-237

  Eyler, Fonda Davis ^a   Behnke, Marylou ^a   Conlon, Michael ^b   Woods, Nanci Stewart ^c   Wobie, Kathleen ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b Department of Statistics University of Florida ^*  (United States)

^c AUSTIN PEAY STATE UNIVERSITY   (United States)

Author keywords

Fetal growth; Pregnancy outcome; Prenatal crack cocaine

Indexed keywords

COCAINE;

ADULT; ARTICLE; BODY HEIGHT; CONTROLLED STUDY; DRUG ABUSE; FEMALE; FETUS GROWTH; FETUS OUTCOME; HEAD CIRCUMFERENCE; HUMAN; MAJOR CLINICAL STUDY; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL;

EID: 0031910164     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.101.2.229     Document Type: Article

References (88)

1. Farrar HC, Kearns GL. Cocaine. Clinical pharmacology and toxicology. J Pediatr. 1989;115:665-675
2. Johanson CE, Fischman MW. The pharmacology of cocaine related to its abuse. Pharmacol Rev. 1989;41:3-52
3. Chasnoff IJ, Keith LG, Schnoll SH. Perinatal aspects of maternal addiction. Curr Probl Obstet Gynecol Fertil. 1986;9:401-440
4. O'Malley PM, Bachman JG, Johnston LD. Period, age, and cohort effects on substance use among young Americans: a decade of change, 1976-86. Am J Public Health. 1988;78:1315-1321
5. Acker D, Sachs BP, Tracey KJ, Wise WE. Abruptio placentae associated with cocaine use. Am J Obstet Gynecol. 1983;146:220-221
6. Chasnoff IJ, Bussey ME, Savich R, Stack CM. Perinatal cerebral infarction and maternal cocaine use. J Pediatr. 1986;456-459
7. Bingol N, Fuchs M, Diaz V, Stone RK, Gromisch DS. Teratogenicity of cocaine in humans. J Pediatr. 1987;110:93-96
8. Teske MP, Trese MT. Retinopathy of prematurity-like fundus and persistent hyperplastic primary vitreous associated with maternal cocaine use. Am J Ophthalmol. 1987;103:719-720
9. Chasnoff IJ, Chisum GM, Kaplan WE. Maternal cocaine use and genitourinary tract malformations. Teratology. 1988;37:201-204
10. Telsey AM, Merrit A, Dixon SD. Cocaine exposure in a term neonate: necrotizing enterocolitis as a complication. Clin Pediatr. 1988;27:547-550
11. Chasnoff IJ, Griffith DR, MacGregor S, Dirkes K, Burns KA. Temporal patterns of cocaine use in pregnancy. JAMA. 1989;261:1741-1744
12. Chávez GF, Mulinare J, Cordero JF. Maternal cocaine use during early pregnancy as a risk factor for congenital urogenital anomalies. JAMA. 1989;262:795-798
13. Geggel RL, McInerny J, Estes NAM. Transient neonatal ventricular tachycardia associated with maternal cocaine use. Am J Cardiol. 1989;63: 383-384
14. Little BB, Snell LM, Klein VR, Gilstrap LC. Cocaine abuse during pregnancy: maternal and fetal implications. Obstet Gynecol. 1989;73: 157-160
15. Reznik VM, Anderson J, Griswold WR, Segall ML, Murphy JL, Mendoza SA. Successful fibrinolytic treatment of arterial thrombosis and hypertension in a cocaine-exposed neonate. Pediatrics. 1989;84:735-738
16. Spires MC, Gordon EF, Choudhuri M, Maldonado E, Chan R. Intracranial hemorrhage in a neonate following prenatal cocaine exposure. Pediatr Neurol. 1989;5:324-326
17. Hoyme HE, Jones KL, Dixon SD, et al. Prenatal cocaine exposure and fetal vascular disruption. Pediatrics. 1990;85:743-747
18. Miller BM, Rosario PG, Prakash K, Patel HK, Gerst PH. Neonatal intestinal perforation: the "crack" connection. Am J Gastroenterol. 1990; 85:767-769
19. Perlow JH, Schlossberg DL, Strassner HT. Intrapartum cocaine use: a case report. J Reprod Med. 1990;35:978-980
20. Greenfield SP, Rutigliano E, Steinhardt G, Elder JS. Genitourinary tract malformations and maternal cocaine abuse. Urology. 1991;37:455-459
21. Hannig VL, Phillips JA. Maternal cocaine abuse and fetal anomalies: evidence for teratogenic effects of cocaine. South Med J. 1991;84:498-499
22. Lipshultz SE, Frassica JJ, Orav EJ. Cardiovascular abnormalities in infants prenatally exposed to cocaine. J Pediatr. 1991;118:44-51
23. Shaw GM, Malcoe LH, Lammer EJ, Swan SH. Maternal use of cocaine during pregnancy and congenital cardiac anomalies. J Pediatr. 1991;118: 167-168
24. Tichenor GA, Ahn SS, Lazerson J. Cocaine exposure in a newborn. Hosp Pract. 1991;26:31-34
25. Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med. 1985;313:666-669
26. Madden JD, Payne TF, Miller S. Maternal cocaine abuse and effect on the newborn. Pediatrics 1986;77:209-211
27. MacGregor SN, Keith LG, Chasnoff IJ, et al. Cocaine use during pregnancy: adverse perinatal outcome. Am J Obstet Gynecol. 1987;157: 686-690
28. Cherukuri R, Minkoff H, Feldman J, Parekh A, Glass L. A cohort study of alkaloidal cocaine ("crack") in pregnancy. Obstet Gynecol. 1988;72: 147-151
29. Hadeed AJ, Siegel SR. Maternal cocaine use during pregnancy: effect on the newborn infant. Pediatrics. 1989;84:205-210
30. Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med. 1989;320:762-768
31. Gillogley KM, Evans AT, Hansen RL, Samuels SJ, Batra KK. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol. 1990;163: 1535-1542
32. Rosenstein BJ, Wheeler JS, Heid PL. Congenital renal abnormalities in infants with in utero cocaine exposure. J Urol. 1990;144:110-112
33. Coles CD, Platzman KA, Smith I, James ME, Falek A. Effects of cocaine and alcohol use in pregnancy on neonatal growth and neurobehavioral status. Neurotoxicol Teratol. 1992;14:23-33
34. Richardson GA, Day NL. Detrimental effects of prenatal cocaine exposure: illusion or reality? J Am Acad Child Adolesc Psychiatry. 1994; 33:28-34
35. Doering PL, Davidson CL, LaFauce L, Williams CA. Effects of cocaine on the human fetus: a review of clinical studies. DICP. 1989;23:639-645
36. Chouteau M, Namerow PB, Leppert P. The effect of cocaine abuse on birth weight and gestational age. Obstet Gynecol. 1988;72:351-354
37. Fulroth R, Phillips B, Durand DJ. Perinatal outcome of infants exposed to cocaine and/or heroin in utero. Am J Dis Child. 1989;143:905-910
38. Keith LG, MacGregor S, Friedell S, Rosner M, Chasnoff IJ, Sciarra JJ. Substance abuse in pregnant women: recent experience at the Perinatal Center for Chemical Dependence of Northwestern Memorial Hospital. Obstet Gynecol. 1989;73:715-720
39. MacGregor SN, Keith LG, Bachicha JA, Chasnoff IJ. Cocaine abuse during pregnancy: correlation between prenatal care and perinatal outcome. Obstet Gynecol. 1989;74:882-885
40. Neerhof MG, MacGregor SN, Retzky SS, Sullivan TP. Cocaine abuse during pregnancy: periparrum prevalence and perinatal outcome. Am J Obstet Gynecol. 1989;161:633-638
41. Petitti DB, Coleman C. Cocaine and the risk of low birth weight. Am J Public Health 1990;80:25-28
42. van de Bor M, Walther FJ, Ebrahimi M. Decreased cardiac output in infants of mothers who abused cocaine. Pediatrics. 1990;85:30-32
43. van de Bor M, Walther FJ, Sims ME. Increased cerebral blood flow velocity in infants of mothers who abuse cocaine. Pediatrics. 1990;85: 733-736
44. Dombrowski MP, Wolfe HM, Welch RA, Evans MI. Cocaine abuse is associated with abruptio placentae and decreased birth weight, but not shorter labor. Obstet Gynecol. 1991;77:139-141
45. Eisen LN, Field TM, Bandstra ES, et al. Perinatal cocaine effects on neonatal stress behavior and performance on the Brazelton Scale. Pediatrics. 1991;88:477-480
46. Handler A, Kistin N, Davis F, Ferré C. Cocaine use during pregnancy: perinatal outcomes. Am J Epidemiol. 1991;133:818-825
47. Little BB, Snell LM. Brain growth among fetuses exposed to cocaine in utero: asymmetrical growth retardation. Obstet Gynecol. 1991;77:361-364
48. McCalla S, Minkoff HL, Feldman J, et al. The biologic and social consequences of perinatal cocaine use in an inner-city population: results of an anonymous cross-sectional study. Am J Obstet Gynecol. 1991;164: 625-630
49. Neuspiel DR, Hamel SC, Hochberg E, Greene J, Campbell D. Maternal cocaine use and infant behavior. Neurotoxicol Teratol. 1991;13:229-233
50. Richardson GA, Day NL. Maternal and neonatal effects of moderate cocaine use during pregnancy. Neurotoxicol Teratol. 1991;13:455-460
51. Spence MR, Williams R, DiGregorio GJ, et al. The relationship between recent cocaine use and pregancy outcome. Obstet Gynecol. 1991;78: 326-329
52. Corwin MJ, Lester BJ, Sepkoski C, McLaughlin S, Kayne H, Golub HL. Effects of in utero cocaine exposure on newborn acoustical cry characteristics. Pediatrics. 1992;89:1199-1203
53. Bateman DA, Ng SKC, Hansen CA, Heagarty MC. The effects of intrauterine cocaine exposure in newborns. Am J Public Health. 1993;83: 190-193
54. Black M, Schuler M, Nair P. Prenatal drug exposure: neurodevelopmental outcome and parenting environment. J Pediatr Psychol. 1993;18: 605-620
55. Chiriboga CA, Bateman DA, Brust JCM, Hauser WA. Neurologic findings in neonates with inrrauterine cocaine exposure. Pediatr Neurol. 1993;9:115-119
56. Mayes LC, Granger RH, Frank MA, Schottenfeld R, Bornstein MH. Neurobehavioral profiles of neonates exposed to cocaine prenatally. Pediatrics. 1993;91:778-783
57. Racine A, Joyce T, Anderson R. The association between prenatal care and birth weight among women exposed to cocaine in New York City. JAMA. 1993;270:1581-1586
58. Weathers WT, Crane MM, Sauvain KJ, Blackhurst DW. Cocaine use in women from a defined population: prevalence at delivery and effects on growth in infants. Pediatrics. 1993;91:350-354
59. Woods NS, Eyler FD, Behnke M, Conlon M. Cocaine use during pregnancy: maternal depressive symptoms and infant neurobehavior over the first month. Infant Behav Dev. 1993;16:83-98
60. Eyler FD, Behnke M, Conlon M, Woods NS, Frentzen B. Prenatal cocaine use: a comparison of neonates matched on maternal risk factors. Neurotoxicol Teratol. 1994;16:81-87
61. Singer LT, Arendt R, Song Ly, Warshawsky E, Kliegman R. Direct and indirect interactions of cocaine with childbirth outcomes. Arch Pediatr Adolesc Med 1994;148:959-964
62. King TA, Perlman JM, Laptook AR, Rollins N, Jackson G, Little B. Neurologic manifestations of in utero cocaine exposure in near-term and term infants. Pediatrics. 1995;96:259-264
63. Lutiger B. Graham K, Einarson TR, Koren G. Relationship between gestational cocaine use and pregnancy outcome: a meta-analysis. Teratology. 1991;44:405-414
64. Behnke M, Eyler FD. The consequences of prenatal substance use for the developing fetus, newborn, and young child. Int J Addict. 1993;28: 1341-1391
65. Chiriboga CA. Fetal effects, neurologic complications of drug and alcohol abuse. Neurol Clin. 1993;11:707-728
66. Singer L, Arendt R, Minnes S. Neurodevelopmental effects of cocaine. Current Controversies in Prenatal Care II. Clin Perinatol. 1993;20: 245-262
67. Graham K, Dimitrakoudis D, Pellegrini E, Koren G. Pregnancy outcome following first trimester exposure to cocaine in social users in Toronto, Canada. Vet Hum Toxicol. 1989;31:143-148
68. Mastrogiannis DS, Decavalas GO, Verma U, Tejani N. Perinatal outcome after recent cocaine usage. Obstet Gynecol. 1990;76:8-11
69. Sallee FR, Katikaneni LP, McArthur PD, Ibrahim HM, Nesbitt L, Sethuraman G. Head growth in cocaine-exposed infants: relationship to neonate hair level. J Dev Behav Pediatr. 1995;16:77-81
70. Mirochnick M, Frank DA, Cabrai H, Turner A, Zuckerman B. Relation between meconium concentration of the cocaine metabolite benzoylecgonine and fetal growth. J Pediatr. 1995;126:636-638
71. Lombardero N, Casanova OQ, Behnke M, Eyler FD, Bertholf RL. Measurement of cocaine and metabolites in urine, meconium, and diapers by gas chromatography/mass spectrometry. Ann Clin Lab Sci. 1993;23: 385-393
72. Day NL, Wagener DK, Taylor PM. Measurement of substance abuse during pregnancy: methodologic issues. In: Pinkert TM, ed. Current Research on the Consequences of Maternal Drug Abuse. (Research Monograph No. 59). Rockville, MD: National Institute on Drug Abuse; 1985: 36-47
73. Dunn LM, Dunn LM. Peabody Picture Vocabulary Test-Revised. Circle Pines, MN: American Guidance Service; 1981
74. Jacobson SW, Jacobson JL, Sokol RJ, Martier SS, Ager JW, Kaplan MG. Maternal recall of alcohol, cocaine, and marijuana use during pregnancy. Neurotoxicol Teratol. 1991;13:535-540
75. Frank DA, Zuckerman BS, Amaro H, et al. Cocaine use during pregnancy: prevalence and correlates. Pediatrics. 1988;82:888-895
76. Mule SJ, Casella GA. Confirmation of marijuana, cocaine, morphine, codeine, amphetamine, methamphetamine, phencyclidine by GC/MS in urine following immunoassay screening. J Anal Toxicol. 1988;12: 102-107
77. Dubowitz LMS, Dubowitz V, Goldberg C. Clinical assessment of gestational age in the newborn infant. J Pediatr. 1970;77:1-10
78. Kliegman RM, King KC. Intrauterine growth retardation: determinants of aberrant fetal growth. In: Fanaroff AA, Martin RJ, eds. Behrman's Neonatal-Perinatal Medicine. St Louis, MO: CV Mosby Co; 1983
79. Hobel CJ, Hyvarinen MA, Okada DM, Oh W. Prenatal and intrapartum high-risk screening. I. Prediction of the high-risk neonate. Am J Obstet Gynecol. 1973;117:1-9
80. Hobel CJ, Youkeles L, Forsythe A. Prenatal and intrapartum high-risk screening, II. Risk factors reassessed. Am J Obstet Gynecol. 1979;135: 1051-1056
81. Battaglia FC, Lubchenco LO. A practical classification of newborn infants by weight and gestarional age. J Pediatr. 1967:159-163
82. Kaye K, Elkind L, Goldberg D, Tytun A. Birth outcomes for infants of drug abusing mothers. NY State J Med. 1989;89:256-261
83. Broekhuizen FF, Utrie J, Van Mullem C. Drug use or inadequate prenatal care? Adverse pregnancy outcome in an urban setting. Am J Obstet Gynecol. 1992;166:1747-1756
84. Ryan L, Ehrlich S, Finnegan L. Cocaine abuse in pregnancy: effects on the fetus and newborn. Neurotoxicol Teratol 1987;9:295-299
85. Moliterno DJ, Willard JE, Lange RA, et al. Coronary-artery vasoconstriction induced by cocaine, cigarette smoking, or both. N Engl J Med. 1994;330:454-459
86. Neuspiel DR, Markowitz M, Drucker E. Intrauterine cocaine, lead, and nicotine exposure and fetal growth. Am J Public Health. 1994;9: 1492-1495
87. Hutchings DE. The puzzle of cocaine's effects following maternal use during pregnancy: are there reconcilable differences? Neurotoxicol Teratol. 1993;15:281-286
88. Griffith DR, Azuma SD, Chasnoff IJ. Three-year outcome of children exposed prenatally to drugs. J Am Acad Child Adolesc Psychiatry. 1994;33:20-27